1,605 results on '"Sack, David"'
Search Results
2. We need to start child-proofing pot
3. Gut microbiota shifts favorably with delivery of handwashing with soap and water treatment intervention in a prospective cohort (CHoBI7 trial)
4. Psychosocial Factors Mediating the Effect of the CHoBI7 Mobile Health Program on Handwashing with Soap and Household Stored Water Quality: A Randomized Controlled Trial
5. Evaluation of a rapid diagnostic test for detection of Vibrio choleraeO1 in the Democratic Republic of the Congo: Preventative intervention for cholera for 7 days (PICHA7 program)
6. Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic E. coli Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701)
7. An innovative approach in monitoring oral cholera vaccination campaign: integration of a between-round survey
8. The Impact of Non-Dysentery Shigella Infection on the Growth and Health of Children over Time (INSIGHT)—A Prospective Case–Control Study Protocol.
9. NewVibrio choleraesequences from Eastern and Southern Africa alter our understanding of regional cholera transmission
10. MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1–CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic Escherichia coli (ETEC)
11. The Antimicrobial Resistance of Enterotoxigenic Escherichia coli from Diarrheal Patients and the Environment in Two Geographically Distinct Rural Areas in Bangladesh over the Years
12. Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine
13. Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
14. Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells
15. Seroconversion and Kinetics of Vibriocidal Antibodies during the First 90 Days of Re-Vaccination with Oral Cholera Vaccine in an Endemic Population.
16. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis
17. A broadly immunogenic polyvalent Shigella multiepitope fusion antigen protein protects against Shigella sonnei and Shigella flexneri lethal pulmonary challenges in mice
18. Corrigendum : Scaling up zinc treatment of childhood diarrhoea in Bangladesh: theoretical and practical considerations guiding the SUZY Project
19. Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development
20. Three transmission events of Vibrio cholerae O1 into Lusaka, Zambia
21. The Controlled Human Infection Model for Enterotoxigenic Escherichia coli
22. Epidemiology of Enterotoxigenic Escherichia coli among Children and Adults Seeking Care at Hospitals in Two Geographically Distinct Rural Areas in Bangladesh.
23. Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic Escherichia coli CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic E. coli H10407 in Healthy Adult Volunteers
24. Efficacy of an Enterotoxigenic Escherichia coli (ETEC) Vaccine on the Incidence and Severity of Traveler’s Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity Score
25. Dilip Mahalanabis (12 November 1934–16 October 2022)
26. Immunogenicity and Protection From a Single Dose of Internationally Available Killed Oral Cholera Vaccine : A Systematic Review and Metaanalysis
27. Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model : A Randomized, Double-Blind, Placebo-Controlled Trial
28. Psychosocial Factors Mediating the Effect of the CHoBI7 Intervention on Handwashing with Soap: A Randomized Controlled Trial
29. Self-Limiting Nature of Seasonal Cholera Epidemics: Role of Host-Mediated Amplification of Phage
30. Seasonal Epidemics of Cholera Inversely Correlate with the Prevalence of Environmental Cholera Phages
31. Genetic Diversity and Virulence Potential of Environmental Vibrio cholerae Population in a Cholera-Endemic Area
32. Psychosocial Factors Mediating the Effect of the CHoBI7 Intervention on Handwashing With Soap : A Randomized Controlled Trial
33. Prioritizing interventions for cholera control in Kenya, 2015–2020
34. Development of a Scorecard to Monitor Progress toward National Cholera Elimination: Its Application in Uganda
35. CTXΦ-Independent Production of the RS1 Satellite Phage by Vibrio cholerae
36. Reduction of Cholera in Bangladeshi Villages by Simple Filtration
37. Emergence and Evolution of Vibrio cholerae O139
38. Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study
39. The quality of drinking and domestic water from the surface water sources (lakes, rivers, irrigation canals and ponds) and springs in cholera prone communities of Uganda: an analysis of vital physicochemical parameters
40. Formative research to scale up a handwashing with soap and water treatment intervention for household members of diarrhea patients in health facilities in Dhaka, Bangladesh (CHoBI7 program)
41. Randomized, Double-Blind Study in Healthy Adults to Assess the Boosting Effect of Vaqta or Havrix after a Single Dose of Havrix
42. Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study
43. Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity
44. Campylobacter jejuni transcriptional and genetic adaptation during human infection
45. Food Hygiene and Fecal Contamination on the Household Compound are Associated with Increased Pediatric Diarrhea in Urban Bangladesh (CHoBI7 Program)
46. Reduced Diarrhea Prevalence and Improvements in Handwashing with Soap and Stored Drinking Water Quality Associated with Diarrheal Disease Awareness Measured by Interactive Voice Response Messages in the CHoBI7 Mobile Health Program
47. Antibodies derived from an enterotoxigenic Escherichia coli (ETEC) adhesin tip MEFA (multiepitope fusion antigen) against adherence of nine ETEC adhesins: CFA/I, CS1, CS2, CS3, CS4, CS5, CS6, CS21 and EtpA
48. Transcriptomic Analysis of the Host Response and Innate Resilience to Enterotoxigenic Escherichia coli Infection in Humans
49. Enterotoxigenic Escherichia coli Pathogenic for Man: Biological and Immunological Aspects of Fimbrial Colonization Factor Antigens
50. Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.